By Dr Joanne Kanaan (Omini)2024-06-11T10:00:27
Introducing Joanne Kanaan, CEO and co-founder of the French startup Omini. To meet the new challenges of decentralised and personalised healthcare, Omini is developing a multiplex blood testing platform for outpatient management using a new patented biosensor technology. Joanne obtained a PhD in biochemistry and biophysics from the Ecole ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-16T09:00:00Z
By Simon Cawley
2024-03-08T10:00:25
Sponsored by Molecular Devices
2024-01-26T13:22:42
Sponsored by bit.bio
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-01-06T10:25:33
Sponsored by Leica Microsystems
Site powered by Webvision Cloud